Literature DB >> 18475504

Suppression of monocyte and neutrophil function by recombinant IL-2.

S E Smith1, G D Warren, Y H Thong, J G McCormack.   

Abstract

Little IS known about the influence of IL-2 on phagocytes. We now describe the effects of human recombinant IL-2 on human neutrophil and monocyte functions related to mobility, phagocytosis, glucose uptake, respiration and degranulation. Neutrophil adherence and hexose monophosphate shunt activities were both suppressed after incubation with IL-2. IL-2 had no effect on neutrophil migration, phagocytosis, deoxyglucose uptake or degranulation, ionocytes demonstrated a greater sensitivity to IL-2 with suppression of monocyte adherence, random and stimulated migration, glucose uptake and hexose monophosphate shunt activity, even after addition of phorbol myristate acetate. Monocyte phagocytosis and degranulation were not affected. All of the effects observed were dose-dependent within a biologically active range for IL-2. These studies suggest that IL-2 may have an important down-regulatory role across a broad range of monocyte functions including movement, deoxyglucose uptake and respiration. However, its role in regulation of neutrophil function is limited to adherence and respiration. IL-2 may be a more versatile cytokine than has previously been appreciated.

Entities:  

Year:  1993        PMID: 18475504      PMCID: PMC2365381          DOI: 10.1155/S0962935193000080

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  22 in total

1.  Interleukin-2, anti-interleukin-2 receptor antibody, and activation of macrophages.

Authors:  M Belosevic; C A Nacy
Journal:  Cell Immunol       Date:  1990-07       Impact factor: 4.868

Review 2.  Parameters of neutrophil activation: models of priming and deactivation.

Authors:  A I Tauber; A B Karnad; K L Hartshorn; J B Myers; J H Schwartz
Journal:  Prog Clin Biol Res       Date:  1989

Review 3.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.

Authors:  C A Dinarello
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 4.  The neutrophil, a professional killer of bacteria, may be controlled by T cells.

Authors:  P A Campbell
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.

Authors:  A Naldini; W R Fleischmann; Z K Ballas; K D Klimpel; G R Klimpel
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

6.  Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

Authors:  M Hoyer; T Meineke; W Lewis; B Zwilling; J Rinehart
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

7.  Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.

Authors:  K Hellstrand; S Hermodsson
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

8.  An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy.

Authors:  M S Klempner; R Noring; J W Mier; M B Atkins
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

9.  Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro.

Authors:  A S Fauci
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

10.  Interleukin 2 inhibits antigen-stimulated lymphokine synthesis in helper T cells by inhibiting calcium-dependent signalling.

Authors:  G Otten; K C Herold; F W Fitch
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.